- Vacquinol-1
-
- $1.00 / 1KG
-
2020-01-02
- CAS:5428-80-8
- Min. Order: 1KG
- Purity: Min98% HPLC
- Supply Ability: g/kg/ton
|
| | [2-(4-chlorophenyl)quinolin-4-yl]-(2-piperidyl)methanol Basic information |
| | [2-(4-chlorophenyl)quinolin-4-yl]-(2-piperidyl)methanol Chemical Properties |
| Melting point | 198-199.5 °C | | Boiling point | 551.4±50.0 °C(Predicted) | | density | 1.244±0.06 g/cm3(Predicted) | | storage temp. | Store at -20°C | | solubility | DMF: 10 mg/ml; DMF:PBS(pH 7.2)(1:1): 0.5 mg/ml; DMSO: 1 mg/ml; Ethanol: 0.25 mg/ml | | form | A crystalline solid | | pka | 13.22±0.20(Predicted) |
| | [2-(4-chlorophenyl)quinolin-4-yl]-(2-piperidyl)methanol Usage And Synthesis |
| Description | Vacquinols are a new class of quinine-derivatives that stimulate death in glioblastoma cells by massive macropinocytotic vacuolization, ATP depletion, and cytoplasmic membrane rupture. A key effector of vacquinols is MAPK kinase 4 (MKK4). Vacquinol-1 is an activator of MKK4-dependent macropinocytotic cell death in glioblastoma cells. It induces ATP depletion in glioblastoma cells (IC50 = 3.14 μM at 1 day) without affecting fibroblasts, embryonic stem cells, or osteosarcoma cells. Vacquinol-1 is orally bioavailable with good brain penetrance and excellent pharmacokinetics. Oral administration of vacquinol-1 (20 mg/kg once daily for five days) substantially impairs the growth of engrafted glioblastoma cell tumors in mice and prolongs survival. | | Uses | Vacquinol-1 is in the vacquinol class of quinine derivatives that stimulate death in glioblastoma cells through massive macropinocytotic vacuolization, ATP depletion and eventual cytoplasmic membrane rupture. |
| | [2-(4-chlorophenyl)quinolin-4-yl]-(2-piperidyl)methanol Preparation Products And Raw materials |
|